Cargando…
Obstructive sleep apnea and cardiovascular risk
Obstructive sleep apnea (OSA) is a form of sleep disordered breathing characterized by episodes of apnea (during sleep) lasting at least 10 seconds per episode. The apneic periods are associated with arterial hypoxemia and disruption of normal sleep as a result of awakenings. It is increasingly bein...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2387304/ https://www.ncbi.nlm.nih.gov/pubmed/18516275 |
_version_ | 1782155310431993856 |
---|---|
author | Dorasamy, Punginathn |
author_facet | Dorasamy, Punginathn |
author_sort | Dorasamy, Punginathn |
collection | PubMed |
description | Obstructive sleep apnea (OSA) is a form of sleep disordered breathing characterized by episodes of apnea (during sleep) lasting at least 10 seconds per episode. The apneic periods are associated with arterial hypoxemia and disruption of normal sleep as a result of awakenings. It is increasingly being recognized that OSA is a public health hazard and there is increasing evidence that it is associated with an increase in morbidity (and possibly mortality). Patients with OSA also utilize the healthcare resources at higher rates than control patients long before their diagnosis is confirmed. Early recognition of this condition may lead to earlier treatments (eg, nasal CPAP) with reduction of the risk of cardiovascular diseases such as hypertension, ischemic heart disease, arrhythmias, platelet activation and pulmonary hypertension. |
format | Text |
id | pubmed-2387304 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-23873042008-05-30 Obstructive sleep apnea and cardiovascular risk Dorasamy, Punginathn Ther Clin Risk Manag Review Obstructive sleep apnea (OSA) is a form of sleep disordered breathing characterized by episodes of apnea (during sleep) lasting at least 10 seconds per episode. The apneic periods are associated with arterial hypoxemia and disruption of normal sleep as a result of awakenings. It is increasingly being recognized that OSA is a public health hazard and there is increasing evidence that it is associated with an increase in morbidity (and possibly mortality). Patients with OSA also utilize the healthcare resources at higher rates than control patients long before their diagnosis is confirmed. Early recognition of this condition may lead to earlier treatments (eg, nasal CPAP) with reduction of the risk of cardiovascular diseases such as hypertension, ischemic heart disease, arrhythmias, platelet activation and pulmonary hypertension. Dove Medical Press 2007-12 2007-12 /pmc/articles/PMC2387304/ /pubmed/18516275 Text en © 2007 Dove Medical Press Limited. All rights reserved |
spellingShingle | Review Dorasamy, Punginathn Obstructive sleep apnea and cardiovascular risk |
title | Obstructive sleep apnea and cardiovascular risk |
title_full | Obstructive sleep apnea and cardiovascular risk |
title_fullStr | Obstructive sleep apnea and cardiovascular risk |
title_full_unstemmed | Obstructive sleep apnea and cardiovascular risk |
title_short | Obstructive sleep apnea and cardiovascular risk |
title_sort | obstructive sleep apnea and cardiovascular risk |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2387304/ https://www.ncbi.nlm.nih.gov/pubmed/18516275 |
work_keys_str_mv | AT dorasamypunginathn obstructivesleepapneaandcardiovascularrisk |